Boehringer Seeks To Divide Claims In AWP Case
Boehringer Ingelheim Corp. is seeking to split up for trial certain claims against it in a case alleging it defrauded Medicare and Medicaid programs by reporting inflated drug prices....To view the full article, register now.
Already a subscriber? Click here to view full article